Cohen Klingenstein’s Bristol-Myers Squibb BMY Stock Holding History

Cohen Klingenstein’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.74M	Hold	47,559	–	–	0.08%	104
2026 Q1	$2.88M	Hold	47,559	–	–	0.09%	97
2025 Q4	$2.57M	Hold	47,559	–	–	0.08%	105
2025 Q3	$2.14M	Hold	47,559	–	–	0.07%	112
2025 Q2	$2.2M	Hold	47,559	–	–	0.07%	113
2025 Q1	$2.9M	Hold	47,559	–	–	0.11%	91
2024 Q4	$2.69M	Sell	47,559 -21,000	-31%	-$1.17M	0.09%	96
2024 Q3	$3.55M	Sell	68,559 -841	-1%	-$39.5K	0.12%	96
2024 Q2	$2.88M	Hold	69,400	–	–	0.1%	101
2024 Q1	$3.76M	Hold	69,400	–	–	0.14%	93
2023 Q4	$3.56M	Hold	69,400	–	–	0.15%	92
2023 Q3	$4.03M	Hold	69,400	–	–	0.18%	82
2023 Q2	$4.44M	Hold	69,400	–	–	0.19%	79
2023 Q1	$4.81M	Hold	69,400	–	–	0.23%	74
2022 Q4	$4.99M	Hold	69,400	–	–	0.25%	71
2022 Q3	$4.93M	Hold	69,400	–	–	0.26%	68
2022 Q2	$5.34M	Hold	69,400	–	–	0.27%	66
2022 Q1	$5.07M	Hold	69,400	–	–	0.21%	77
2021 Q4	$4.33M	Sell	69,400 -13,654	-16%	-$801K	0.17%	90
2021 Q3	$4.91M	Sell	83,054 -12,062	-13%	-$794K	0.21%	79
2021 Q2	$6.36M	Hold	95,116	–	–	0.27%	66
2021 Q1	$6M	Hold	95,116	–	–	0.28%	68
2020 Q4	$5.9M	Hold	95,116	–	–	0.29%	66
2020 Q3	$5.74M	Hold	95,116	–	–	0.32%	66
2020 Q2	$5.59M	Hold	95,116	–	–	0.34%	65
2020 Q1	$5.3M	Hold	95,116	–	–	0.39%	59
2019 Q4	$6.11M	Buy	95,116 +50,116	+111%	+$2.87M	0.35%	66
2019 Q3	$2.28M	Buy	45,000 +21,000	+88%	+$987K	0.14%	116
2019 Q2	$1.09M	Buy	+24,000	New	+$1.12M	0.08%	145

Other funds holding BMY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Cohen Klingenstein's BMY Position: Q2 2026 in Review

Cohen Klingenstein held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 47,559 shares worth $2.74M. The position accounts for 0.08% of the portfolio, ranked #104.

Cohen Klingenstein first reported a position in BMY in Q2 2019 and has held it in 29 quarters since. The position peaked at $6.36M in Q2 2021. 864 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Cohen Klingenstein held 47,559 shares of Bristol-Myers Squibb worth $2.74M as of Q2 2026.
Cohen Klingenstein left its Bristol-Myers Squibb share count unchanged in Q2 2026.
Bristol-Myers Squibb made up 0.08% of Cohen Klingenstein's portfolio in Q2 2026, its #104 holding.
Cohen Klingenstein first reported a position in Bristol-Myers Squibb in Q2 2019 and has held it in 29 quarters since.
Cohen Klingenstein's Bristol-Myers Squibb position peaked at $6.36M in Q2 2021.
864 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Cohen Klingenstein's 13F filing for Q2 2026, filed 15 Jul 2026.